Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2024

Open Access 01-12-2024 | Research

Plasma aldosterone response to ACTH stimulation test for diagnosis of primary aldosteronism: a cross-sectional study

Authors: Worapaka Manosroi, Pichitchai Atthakomol, Piti Inthaphan, Supornthip Hintong

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

The diagnosis of primary aldosteronism (PA) requires screening and confirmation testing. The present study examined whether the 1 µg ACTH stimulation test for plasma aldosterone concentration (PAC) can accurately diagnose PA by bypassing the regular confirmatory steps of PA diagnosis.

Methods

A cross-sectional study with a total of 36 patients with an aldosterone-renin ratio (ARR) > 20 ng/dL per ng/m/hr were included. The confirmation test for PA was performed by saline infusion and the patients were categorized into PA and non-PA. PAC was collected at 20 and 40 min after 1 µg ACTH stimulation test. Multivariable logistic regression analysis was performed, and the associations are presented as odds ratios (OR) and 95% confidence intervals (CI). Diagnostic accuracy is presented as AuROC.

Results

Multivariable analysis found only PAC at 20 min after ACTH stimulation showed significant association with a diagnosis of PA (OR 1.18, 95%CI (0.99, 1.31), p = 0.040). AuROC for this value was 0.95 and the proposed cut-off was 52 ng/dL with a sensitivity of 71.4% and a specificity of 96.6%.

Conclusions

Diagnosing PA may be aided by PAC at 20 min following 1 µg ACTH stimulation. This value may be used with patients for whom the confirmation test for PA cannot be conducted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, Vaidya A. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020;173(1):10–20.CrossRefPubMedPubMedCentral Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, Vaidya A. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020;173(1):10–20.CrossRefPubMedPubMedCentral
2.
go back to reference Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF. Jr: the management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metabolism. 2016;101(5):1889–916.CrossRef Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF. Jr: the management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metabolism. 2016;101(5):1889–916.CrossRef
3.
go back to reference Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F, Maccario M. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2006;91(7):2618–23.CrossRefPubMed Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F, Maccario M. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2006;91(7):2618–23.CrossRefPubMed
4.
go back to reference Nanba K, Tsuiki M, Umakoshi H, Nanba A, Hirokawa Y, Usui T, Tagami T, Shimatsu A, Suzuki T, Tanabe A, et al. Shortened saline infusion test for subtype prediction in primary aldosteronism. Endocrine. 2015;50(3):802–6.CrossRefPubMed Nanba K, Tsuiki M, Umakoshi H, Nanba A, Hirokawa Y, Usui T, Tagami T, Shimatsu A, Suzuki T, Tanabe A, et al. Shortened saline infusion test for subtype prediction in primary aldosteronism. Endocrine. 2015;50(3):802–6.CrossRefPubMed
5.
go back to reference Hattangady NG, Olala LO, Bollag WB, Rainey WE. Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol. 2012;350(2):151–62.CrossRefPubMed Hattangady NG, Olala LO, Bollag WB, Rainey WE. Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol. 2012;350(2):151–62.CrossRefPubMed
6.
go back to reference Kem DC, Weinberger MH, Higgins JR, Kramer NJ, Gomez-Sanchez C, Holland OB. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab. 1978;46(4):552–60.CrossRefPubMed Kem DC, Weinberger MH, Higgins JR, Kramer NJ, Gomez-Sanchez C, Holland OB. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab. 1978;46(4):552–60.CrossRefPubMed
7.
go back to reference Sonoyama T, Sone M, Miyashita K, Tamura N, Yamahara K, Park K, Oyamada N, Taura D, Inuzuka M, Kojima K, et al. Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma. J Clin Endocrinol Metab. 2011;96(9):2771–8.CrossRefPubMed Sonoyama T, Sone M, Miyashita K, Tamura N, Yamahara K, Park K, Oyamada N, Taura D, Inuzuka M, Kojima K, et al. Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma. J Clin Endocrinol Metab. 2011;96(9):2771–8.CrossRefPubMed
8.
go back to reference Moriya A, Yamamoto M, Kobayashi S, Nagamine T, Takeichi-Hattori N, Nagao M, Harada T, Tanimura-Inagaki K, Onozawa S, Murata S, et al. ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism. Endocr J. 2017;64(1):65–73.CrossRefPubMed Moriya A, Yamamoto M, Kobayashi S, Nagamine T, Takeichi-Hattori N, Nagao M, Harada T, Tanimura-Inagaki K, Onozawa S, Murata S, et al. ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism. Endocr J. 2017;64(1):65–73.CrossRefPubMed
9.
go back to reference Umakoshi H, Xiaomei Y, Ichijo T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, et al. Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism. Clin Endocrinol (Oxf). 2017;86(2):170–6.CrossRefPubMed Umakoshi H, Xiaomei Y, Ichijo T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, et al. Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism. Clin Endocrinol (Oxf). 2017;86(2):170–6.CrossRefPubMed
10.
go back to reference Terui K, Kageyama K, Nigawara T, Moriyama T, Sakihara S, Takayasu S, Tsushima Y, Watanki Y, Yamagata S, Sugiyama A, et al. Evaluation of the (1–24) adrenocorticotropin stimulation test for the diagnosis of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2016;17(1):1470320315625703.CrossRefPubMedPubMedCentral Terui K, Kageyama K, Nigawara T, Moriyama T, Sakihara S, Takayasu S, Tsushima Y, Watanki Y, Yamagata S, Sugiyama A, et al. Evaluation of the (1–24) adrenocorticotropin stimulation test for the diagnosis of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2016;17(1):1470320315625703.CrossRefPubMedPubMedCentral
11.
go back to reference Inoue K, Omura M, Sugisawa C, Tsurutani Y, Saito J, Nishikawa T. Clinical utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone suppression for definitive and subtype diagnosis of primary Aldosteronism. Int J Mol Sci 2017, 18(5). Inoue K, Omura M, Sugisawa C, Tsurutani Y, Saito J, Nishikawa T. Clinical utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone suppression for definitive and subtype diagnosis of primary Aldosteronism. Int J Mol Sci 2017, 18(5).
12.
go back to reference Honour JW, Bridges NA, Conway-Phillips E, Hindmarsh PC. Plasma aldosterone response to the low-dose adrenocorticotrophin (ACTH 1–24) stimulation test. Clin Endocrinol (Oxf). 2008;68(2):299–303.CrossRefPubMed Honour JW, Bridges NA, Conway-Phillips E, Hindmarsh PC. Plasma aldosterone response to the low-dose adrenocorticotrophin (ACTH 1–24) stimulation test. Clin Endocrinol (Oxf). 2008;68(2):299–303.CrossRefPubMed
13.
go back to reference Mancini T, Kola B, Mantero F, Arnaldi G. Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to Low-Dose Adrenocorticotropin. J Clin Endocrinol Metabolism. 2003;88(5):1994–8.CrossRef Mancini T, Kola B, Mantero F, Arnaldi G. Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to Low-Dose Adrenocorticotropin. J Clin Endocrinol Metabolism. 2003;88(5):1994–8.CrossRef
14.
go back to reference Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistrè A, Del Pinto R, Fabris B, Fallo F, Fava C, et al. The 2020 Italian society of arterial hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Int J Cardiol Hypertens. 2020;5:100029.CrossRefPubMedPubMedCentral Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistrè A, Del Pinto R, Fabris B, Fallo F, Fava C, et al. The 2020 Italian society of arterial hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Int J Cardiol Hypertens. 2020;5:100029.CrossRefPubMedPubMedCentral
15.
go back to reference Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364–89.CrossRefPubMed Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364–89.CrossRefPubMed
16.
go back to reference Anantharaman R, Menezes G, Yusuf R, Ganapathi B, Ayyar SV, Srinivasan R. The 1 µg cosyntropin test in normal individuals: a reappraisal. Indian J Endocrinol Metab. 2013;17(4):693–6.CrossRefPubMedPubMedCentral Anantharaman R, Menezes G, Yusuf R, Ganapathi B, Ayyar SV, Srinivasan R. The 1 µg cosyntropin test in normal individuals: a reappraisal. Indian J Endocrinol Metab. 2013;17(4):693–6.CrossRefPubMedPubMedCentral
18.
go back to reference Jiang Y, Zhang C, Wang W, Su T, Zhou W, Jiang L, Zhu W, Xie J, Ning G. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2015;100(5):1837–44.CrossRefPubMed Jiang Y, Zhang C, Wang W, Su T, Zhou W, Jiang L, Zhu W, Xie J, Ning G. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2015;100(5):1837–44.CrossRefPubMed
19.
go back to reference Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Debaveye Y, Langouche L, Van den Berghe G. ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study. Intensive Care Med. 2018;44(12):2048–58.CrossRefPubMedPubMedCentral Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Debaveye Y, Langouche L, Van den Berghe G. ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study. Intensive Care Med. 2018;44(12):2048–58.CrossRefPubMedPubMedCentral
20.
go back to reference Stowasser M, Ahmed A, Cowley D, Wolley M, McWhinney B, Ungerer J, Gordon RD. SEATED SALINE SUPPRESSION TESTING FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM. A VALIDATION STUDY. J Hypertens 2018, 36. Stowasser M, Ahmed A, Cowley D, Wolley M, McWhinney B, Ungerer J, Gordon RD. SEATED SALINE SUPPRESSION TESTING FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISM. A VALIDATION STUDY. J Hypertens 2018, 36.
21.
go back to reference Sonoyama T, Sone M, Tamura N, Honda K, Taura D, Kojima K, Fukuda Y, Kanamoto N, Miura M, Yasoda A, et al. Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism. Endocr Connect. 2014;3(4):173–9.CrossRefPubMedPubMedCentral Sonoyama T, Sone M, Tamura N, Honda K, Taura D, Kojima K, Fukuda Y, Kanamoto N, Miura M, Yasoda A, et al. Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism. Endocr Connect. 2014;3(4):173–9.CrossRefPubMedPubMedCentral
Metadata
Title
Plasma aldosterone response to ACTH stimulation test for diagnosis of primary aldosteronism: a cross-sectional study
Authors
Worapaka Manosroi
Pichitchai Atthakomol
Piti Inthaphan
Supornthip Hintong
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01563-y

Other articles of this Issue 1/2024

BMC Endocrine Disorders 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.